Plain-English translation of NCT06329882 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Read our Diabetes Mellitus, Type 2 research guide โPhase 1/2 โ A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This trial is testing whether doxycycline, an antibiotic, can help improve blood sugar control when combined with sitagliptin, a common diabetes medication. Researchers want to see if this combination not only manages diabetes better, but also protects your heart health. The study will compare how well this two-drug approach works compared to sitagliptin alone.
Type 2 diabetes can damage your heart and blood vessels over time. Current medications help, but researchers believe this medication might offer additional benefits beyond just lowering blood sugar, potentially protecting your cardiovascular health as well.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you join, you'll take either sitagliptin alone or sitagliptin combined with doxycycline daily. The study will monitor how well your blood sugar is controlled and track your heart health indicators over time. You'll likely have regular check-ins and blood tests to measure your progress.
AI-generated summary from trial data ยท Jun 1, 2026 ยท Not medical advice
Egypt
Phase
Safety & dosing / Early efficacy
Sponsor
Mostafa Bahaa
Enrollment target
~60 participants
Started
March 2024
Primary completion
March 2026
This trial's estimated completion date has passed โ the record may not be fully up to date.
Age range
40 Years โ 60 Years
Last updated on clinicaltrials.gov in April 2025.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first โ no email needed to get started.